Preventive or therapeutic medicines for diabetes containing fused-heterocyclic compounds or their salts
US7067520B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2001 |
| Grant date | Jun 27, 2006 |
| Priority date | — |
| Expiry date | Sep 23, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a preventive or therapeutic medicine for diabetes containing as an active ingredient a fused-heterocyclic compound of the formula (I′) or its salt:[wherein G is CN, NO2, CO2R4, CHO, SO2NRaRb or CONRaRb; R1 is a halogen atom, a —O—R5 group or a —S—R5 group; R2 is a halogen atom, a —O—R5 group (wherein R5 is as defined above) or an amino group which may be substituted; and each of R8 and R10 which are independent of each other, is a hydrogen atom, a halogen atom or an alkyl group].
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.